MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with E

Empagliflozin

Empagliflozin 10mg tablets

No stability information

Stability notes for Empagliflozin 10mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Empagliflozin 10mg tablets
Empagliflozin 10mg tablets (A A H Pharmaceuticals Ltd)
Empagliflozin 10mg tablets (Boehringer Ingelheim Ltd)
Jardiance 10mg tablets (Boehringer Ingelheim Ltd)
Jardiance 10mg tablets (CST Pharma Ltd)

Empagliflozin 25mg tablets

No stability information

Stability notes for Empagliflozin 25mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Empagliflozin 25mg tablets
Empagliflozin 25mg tablets (A A H Pharmaceuticals Ltd)
Empagliflozin 25mg tablets (Boehringer Ingelheim Ltd)
Jardiance 25mg tablets (Boehringer Ingelheim Ltd)
Jardiance 25mg tablets (CST Pharma Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.